| Status | Study |
| Completed |
Study Name: Safety, Tolerability and PK of Repeat Administration of IV ETI-204 Condition: Inhalational Anthrax Date: 2013-08-02 Interventions: Biological: ETI-204 Monoclonal |
| Completed |
Study Name: A Study to Assess the Safety, Tolerability and PK of a Single IV Dose of ETI-204 in Adult Volunteers Condition: Inhalational Anthrax Date: 2013-08-02 Interventions: Biological: ETI-204 Monoclonal |
| Completed |
Study Name: Efficacy and Safety of Anthrax Vaccine, GC1109 Condition: Anthrax Date: 2013-05-30 Interventions: Biological: Low-dose GC1109 50 |
| Active, not recruiting |
Study Name: Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals Condition: Ischemic Stroke Malignant Edema Date: 2013-02-14 Interventions: Drug: RP-1127 (Glyburide for Injection) Glyburide (5-chloro-N-(4-[N-(cyclohexylcarbamoyl) sulfamoyl]phen |
| Completed |
Study Name: A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels Condition: Anthrax Date: 2013-01-16 Interventions: Biological: AV7909 Anthrax Vac |
| Completed |
Study Name: Ciprofloxacin BioThrax Co-Administration Study Condition: Anthrax Date: 2012-12-14 Interventions: Biological: BioThrax route of |
| Completed |
Study Name: Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution Condition: Infection Date: 2012-09-19 Interventions: Drug: Cipro (Ciprofloxacin, BAYQ3939) Patient treated with Ciproxan without dilution treatment in daily |
| Completed |
Study Name: Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance Condition: Infection Date: 2012-08-07 Interventions: Drug: Ciprofloxacin (BAYQ3939) Patient treated with Ciproxan as a first line treatment in daily clinical |
| Recruiting |
Study Name: BioThrax® (Anthrax) Vaccine in Pregnancy Registry Condition: Pregnancy Complications Pregnancy Outcome Congenital Abnor Date: 2012-07-16 Interventions: Biological: Observational Intervention This is an observational study, therefore no interventions are sp |
| Completed |
Study Name: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule Condition: Bacillus Anthracis (Anthrax) Date: 2012-07-05 Interventions: Biological: BioThrax® Bio |